Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells

With the advent of novel, highly effective therapies for multiple myeloma (MM), classical serologic monitoring appears insufficient for response assessment and prediction of relapse. Moreover, serologic studies in MM are hampered by interference of therapeutic antibodies. The detection of malignant...

Descripción completa

Detalles Bibliográficos
Autores principales: Mack, Elisabeth K. M., Hartmann, Sören, Ross, Petra, Wollmer, Ellen, Mann, Christoph, Neubauer, Andreas, Brendel, Cornelia, Hoffmann, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913458/
https://www.ncbi.nlm.nih.gov/pubmed/35106639
http://dx.doi.org/10.1007/s00277-022-04771-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913458/
https://www.ncbi.nlm.nih.gov/pubmed/35106639
http://dx.doi.org/10.1007/s00277-022-04771-5

Ejemplares similares